Peoples George 4
4 · Calidi Biotherapeutics, Inc. · Filed Jul 11, 2024
Insider Transaction Report
Form 4
Peoples George
Director
Transactions
- Award
Non-Qualified Stock Options (right to buy)
2024-07-01+30,904→ 30,904 totalExercise: $0.19Exp: 2034-07-01→ Common stock (30,904 underlying)
Footnotes (1)
- [F1]Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on July 1, 2024 (the "Grant Date"), the Reporting Person was granted 30,904 non-qualified stock options (the "Options") at the exercise price of $0.193, which is the closing price of the Issuer's common stock on the Grant Date. The Options shall vest in 1/36 per month over three years, commencing on the Grant Date.